BR112016028875A2 - formulações intravaginais compreendendo gnrh - Google Patents
formulações intravaginais compreendendo gnrhInfo
- Publication number
- BR112016028875A2 BR112016028875A2 BR112016028875A BR112016028875A BR112016028875A2 BR 112016028875 A2 BR112016028875 A2 BR 112016028875A2 BR 112016028875 A BR112016028875 A BR 112016028875A BR 112016028875 A BR112016028875 A BR 112016028875A BR 112016028875 A2 BR112016028875 A2 BR 112016028875A2
- Authority
- BR
- Brazil
- Prior art keywords
- gnrh
- formulation
- amount
- intravaginal
- offered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
é oferecida uma formulação intravaginal, compreendendo um ácido carboxílico em uma quantidade de 10-20% p/p da referida formulação, uma base oleaginosa, tendo uma temperatura de fusão entre 30¿c e 38¿c, gnrh ou um análogo do mesmo, em uma quantidade equivalente à quantidade de gnrh entre 10 µg e 600 µg. também é oferecido um para induzir a ovulação em um ruminante usando a formulação.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462012523P | 2014-06-16 | 2014-06-16 | |
PCT/US2015/033951 WO2015195333A1 (en) | 2014-06-16 | 2015-06-03 | Intravaginal formulations comprising gnrh |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112016028875A2 true BR112016028875A2 (pt) | 2017-08-22 |
Family
ID=53773489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016028875A BR112016028875A2 (pt) | 2014-06-16 | 2015-06-03 | formulações intravaginais compreendendo gnrh |
Country Status (14)
Country | Link |
---|---|
US (1) | US20170143786A1 (pt) |
EP (1) | EP3154519A1 (pt) |
JP (1) | JP2017519769A (pt) |
CN (1) | CN106456705A (pt) |
AR (1) | AR100846A1 (pt) |
AU (1) | AU2015277613A1 (pt) |
BR (1) | BR112016028875A2 (pt) |
CA (1) | CA2951532A1 (pt) |
CL (1) | CL2016003220A1 (pt) |
IL (1) | IL249121A0 (pt) |
MX (1) | MX2016016768A (pt) |
RU (1) | RU2016146994A (pt) |
UY (1) | UY36168A (pt) |
WO (1) | WO2015195333A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11376220B2 (en) | 2017-06-30 | 2022-07-05 | Therio, LLC | Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4211769A (en) * | 1977-08-24 | 1980-07-08 | Takeda Chemical Industries, Ltd. | Preparations for vaginal administration |
AU2063197A (en) * | 1996-03-04 | 1997-09-22 | Massachusetts Institute Of Technology | Materials and methods for enhancing cellular internalization |
CN101692985A (zh) * | 2009-09-29 | 2010-04-14 | 浙江大学 | 一种诱导奶牛定时***进行人工授精的方法 |
CN101779988A (zh) * | 2010-02-03 | 2010-07-21 | 李树静 | 一种青年牛高强度重复超数***的方法 |
-
2015
- 2015-06-03 AU AU2015277613A patent/AU2015277613A1/en not_active Abandoned
- 2015-06-03 EP EP15745266.5A patent/EP3154519A1/en not_active Withdrawn
- 2015-06-03 MX MX2016016768A patent/MX2016016768A/es unknown
- 2015-06-03 RU RU2016146994A patent/RU2016146994A/ru unknown
- 2015-06-03 BR BR112016028875A patent/BR112016028875A2/pt not_active Application Discontinuation
- 2015-06-03 WO PCT/US2015/033951 patent/WO2015195333A1/en active Application Filing
- 2015-06-03 US US15/318,851 patent/US20170143786A1/en not_active Abandoned
- 2015-06-03 CA CA2951532A patent/CA2951532A1/en not_active Abandoned
- 2015-06-03 CN CN201580032022.9A patent/CN106456705A/zh active Pending
- 2015-06-03 JP JP2016573959A patent/JP2017519769A/ja active Pending
- 2015-06-15 AR ARP150101903A patent/AR100846A1/es unknown
- 2015-06-15 UY UY0001036168A patent/UY36168A/es not_active Application Discontinuation
-
2016
- 2016-11-22 IL IL249121A patent/IL249121A0/en unknown
- 2016-12-15 CL CL2016003220A patent/CL2016003220A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX2016016768A (es) | 2017-04-04 |
CA2951532A1 (en) | 2015-12-23 |
US20170143786A1 (en) | 2017-05-25 |
CL2016003220A1 (es) | 2017-06-02 |
RU2016146994A (ru) | 2018-07-16 |
JP2017519769A (ja) | 2017-07-20 |
RU2016146994A3 (pt) | 2018-07-16 |
IL249121A0 (en) | 2017-01-31 |
AU2015277613A1 (en) | 2016-12-08 |
UY36168A (es) | 2016-01-29 |
AR100846A1 (es) | 2016-11-02 |
CN106456705A (zh) | 2017-02-22 |
EP3154519A1 (en) | 2017-04-19 |
WO2015195333A1 (en) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2021000343A1 (es) | Inhibidores peptídicos del receptor de interleucina 23 (divisional de la solicitud n° 201800128) | |
CL2018000320A1 (es) | Coadyuvantes basados en aceite (divisional de solicitud 201600650) | |
CO2017005626A2 (es) | Una composición que comprende bacteroides thetaiotaomicron | |
IL255203B (en) | Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders | |
NI201700073A (es) | Benzamidas sustituidas con 1,3-tiazol-2-ilo | |
BR102016017090B8 (pt) | Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável | |
CL2015001984A1 (es) | (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos. | |
WO2015160842A8 (en) | Methods and formulations of capsaicinoids and capsinoids | |
BR112015023391A2 (pt) | formulações compreendendo conjugado droga-anticorpo anti-egfr | |
CL2020000220A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
BR112017012562A2 (pt) | lubrificante para alta temperatura para a indústria alimentícia | |
BR112015019264A2 (pt) | composições farmacêuticas para o tratamento de helicobacter pylori | |
CL2019001053A1 (es) | Formulaciones farmacéuticas y métodos para prepararlas. | |
CO2019002245A2 (es) | Combinación de agonistas de fxr | |
BR112017028137A2 (pt) | agente terapêutico para fibrose | |
AR112291A1 (es) | Composición para su uso en la prevención y/o el tratamiento de la mucositis orogastrointestinal inducida por un tratamiento oncológico | |
BR112018074006A2 (pt) | extrato de farelo de trigo em uma mistura para cuidado capilar | |
BR112016028875A2 (pt) | formulações intravaginais compreendendo gnrh | |
AR108616A1 (es) | Formulación combinada de tres compuestos antivirales | |
CL2020000221A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
BR112017025043A2 (pt) | formulação para cuidado dos cabelos | |
MX2017013879A (es) | Composiciones que comprenden anakinra. | |
IL271596B2 (en) | An emulsion preparation that includes danzol for use in the treatment of bread mucosa conditions | |
BR112017017308A2 (pt) | composição de graxa | |
BR112017017685A2 (pt) | formulações farmacêuticas de inibidor de c1 esterase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |